Navigation Links
Gene Therapy Overcomes Heart Failure In Muscular Dystrophy

Researchers at the University of Pittsburgh have successfully treated heart failure in an animal model that is genetically //prone to develop a human muscular dystrophy. The article detailing this study is published in the Oct. 25 edition of the journal Circulation. The authors say that this is the first time that a gene therapy has been used in a therapeutic way.

Lead author, Xiao Xiao, Ph.D., associate professor of orthopedic surgery at the University of Pittsburgh School of Medicine said that attempts to treat the muscle with genes directed at it have been successful because of inherent characteristics of the muscle itself, 'Previous attempts at systemic gene therapy for muscle have not been very effective because blood vessel capillaries act much like a mosquito net, blocking the gene drugs from reaching the muscle cells. Fortunately, we found a virus that is just small and sneaky enough to get through this net and deliver the therapeutic gene to both skeletal and cardiac muscle cells,' he said.

The virus that was successfully used to deliver the gene to the muscle is named the adeno-associated virus, or AAV, a class of relatively small viruses that do not cause any known disease. Dr Xiao and his team used the AAV-8, which can penetrate the capillary net and thus can be effective in whole body treatments. The team tested this therapy against limb girdle muscular dystrophy, or LGMD. In humans, this condition leads to severe damage and weakness to muscles, particularly around the hips and shoulders and the heart. Naturally, the lifespan is shortened owing to cardiac and respiratory failure. The injection of a high dose of AAV-8 was accompanied by significant improvements in the skeletal and cardiac muscle tones in the affected hamsters. After eight months of gene therapy, the hamsters were found to have completely normal hearts. The untreated LGMD animals died of heart failure or other complications of muscular dystrophy by 37 weeks, while the t reated animals survived beyond the study period of 48 weeks. 'When we began the experiment, we anticipated that the treatment would be effective. However, we never imagined it would be so effective, particularly in protecting against or reversing the damage to the heart caused by this mutation and extending lifespan,' concluded Dr. Tong Zhu, M.D., Ph.D., a research associate in the department of orthopedic surgery and the first author of the study. 'In fact, if this study holds up in human clinical trials, it may have profound implications for the treatment of heart failure.'


'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... ... 2019 , ... Swiss Pet company PerAnimal launches a new unique ... between human and animal while improving the overall wellness of pet companions. , All ... of experience. They are made by hand from organic Swiss herbal condensate and Swiss ...
(Date:4/18/2019)... ... ... She went from learning disabled to honor roll – all because of ... “goofy tests,” performed by Deborah Zelinsky, O.D. , founder of the Mind-Eye Institute ... range of visual awareness, she could only see what was directly in front of ...
(Date:4/17/2019)... , ... April 17, 2019 , ... With Fentanyl overdose ... are working to curb the death toll by looking for an alternative to naloxone. ... National Meeting & Exposition this week. , Naloxone (often known by the name brand ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... a new initiative this April to designate April 19th as World IBS Day ... for research & healthcare professionals in their pursuit to find treatments. Irritable Bowel ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... ... focus on advances in revolutionary diagnostic technologies. This episode is scheduled to air ... In this segment, Innovations will focus on Credo Biomedical Pte. Ltd. (Credo Biomedical), ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... 18, 2019 , ... KVC Kentucky will host the 2nd ... Fasig-Tipton horse farm on May 17, 2019 to raise funds to support KVC ... this elegant venue highlights Kentucky's stunning farmland, prized Thoroughbred horses and beautiful equine ...
(Date:4/17/2019)... ... ... Salt Lake Community College has named Jay K. Francis and ... SLCC’s May 3 Commencement at the Maverik Center, 3200 S. Decker Lake Drive, West ... Family Philanthropy. Richards is president and CEO of SelectHealth. , Francis studied business and ...
(Date:4/17/2019)... HOUSTON (PRWEB) , ... April 17, 2019 , ... What ... improv comedy livestream show? Hosted within the Texas Medical Center’s TMC Innovation Institute, the ... - 26th, 2019, followed by a review by potential employers — all featured in ...
Breaking Medicine Technology: